FRAX Score (10-Year Fracture Risk)
Estimate 10-year probability of major osteoporotic fracture (hip, spine, forearm, humerus) and hip fracture. Simplified risk-factor-based screening for clinic use.
Major osteoporotic fx (10y)
13.0%
Hip + spine + forearm + humerus
Hip fracture (10y)
4.8%
BMI 23.4
Recommendation
High risk (treatment threshold met). Initiate pharmacologic therapy: oral bisphosphonate (alendronate 70 mg/week, risedronate 35 mg/week) is first-line; zoledronate 5 mg IV/year for non-adherent. Consider denosumab if eGFR <35. Pair with calcium + vitamin D.
Build an osteoporosis prevention pathway
DoctorScribe auto-runs FRAX on every postmenopausal patient, schedules DXA when indicated, and tracks bisphosphonate adherence — for orthopaedics, OBGYN and family medicine clinics.
Screen every menopausal patient automatically
DoctorScribe flags FRAX-eligible patients at every visit, integrates DXA reports, and sets bisphosphonate reminders — early prevention without manual tracking.